GSK Gsk Plc

TIDMGSK

RNS Number : 6634E

GlaxoSmithKline PLC

19 July 2016

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
===  ========================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  ================================================ 
 b)   Position/status          CEO, GSK Consumer Healthcare 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Increase in notional interest in Ordinary 
       transaction              Shares following the re-investment of dividends 
                                paid to shareholders on 14 July 2016 on 
                                Ordinary Shares held in the Company's 2009 
                                Performance Share Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                 -----------  ---------- 
                                  GBP16.285    734.658 
                                 -----------  ---------- 
                                  GBP16.285    1,382.343 
                                 -----------  ---------- 
                                  GBP16.285    1,417.369 
                                 -----------  ---------- 
                                  GBP16.285    2,419.656 
                                 -----------  ---------- 
===  ========================  ================================================ 
 d)   Aggregated information 
       Aggregated volume 
       Price 
                                 5,954.026 
                                 GBP16.285 
===  ========================  ================================================ 
 e)   Date of the transaction  2016-07-14 
===  ========================  ================================================ 
 f)   Place of the             n/a 
       transaction 
===  ========================  ================================================ 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHDKLFFQDFEBBX

(END) Dow Jones Newswires

July 20, 2016 02:00 ET (06:00 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024

Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024